Chemical Compound
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1R)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
CAS Registry Number
80952-71-2
Primary record
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1R)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- 库存
- 3,982 克
- 纯度
- 98.4 %
- CAS
- 80952-71-2
化合物标识与属性
- CAS
- 80952-71-2
- PubChem CID
- 21599923
- SMILES
- CC(=CCC[C@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O)C
- Canonical SMILES
- CC(C)=CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C
名称与同义词
- (20R)-Ginsenoside Rh1
- 20(R)-Ginsenoside Rh1
- (R) -ginsenoside Rh1
- Ginsenoside Rh1
- 80952-71-2
- R-Ginsenoside Rh1
- (R)Ginsenoside-Rh1
- (20R)-GinsenosideRh1
- 20(R)Ginsenoside Rh1
- RefChem:1085790
- YCE9FKG6Q8
- Ginsenoside 20(R)-Rh1
- 20(R)--Ginsenoside rh1
- GINSENOSIDE-RH1(R)
- MFCD22200424
- orb1303738
- C36H62O9
- CHEMBL3594353
- SCHEMBL29402793
- EX-A8002R
- CHEBI:228836
- DTXSID101350083
- HY-N1400
- GINSENOSIDE RH1, (20R)-
- MSK169741
- s9318
- ZINC85643762
- AKOS037514527
- ACN-047139
- CCG-270313
- EBC-617179
- FG73799
- AC-34686
- DA-59473
- MS-30906
- J632.113E
- CS-0016818
- FT-0777159
- Y0009
- A901587
- (20R)-Ginsenoside Rh120(R)--Ginsenoside rh1; (R)Ginsenoside-Rh1
- (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-1-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (20R)-6alpha-(beta-D-Glucopyranosyloxy)-3beta,12beta,20-trihydroxydammara-24-ene
- (3|A,6|A,12|A,20R)-3,12,20-Trihydroxydammar-24-en-6-yl |A-D-glucopyranoside
- [(20R)-3beta,12beta,20-Trihydroxy-5alpha-dammar-24-en-6alpha-yl]beta-D-glucopyranoside
- beta-D-Glucopyranoside, (3beta,6alpha,12beta,20R)-3,12,20-trihydroxydammar-24-en-6-yl
- (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((2R)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1R)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-[[(6R,8R,10R,12S,14S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5S,5AR,7S,9AR,9BR,11R,11AR)-7,11-DIHYDROXY-1-[(2R)-2-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-3A,3B,6,6,9A-PENTAMETHYL-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-5-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.,20R)-3,12,20-TRIHYDROXYDAMMAR-24-EN-6-YL